We are a research-based specialty
biopharma company determined
to give people worldwide a longer
and better life

We are developing the first vaccine
in the world for protection against
diarrhoea caused by ETEC in both
travellers and endemic populations

We distribute a wide range of
specialty biopharma products with
focus on vaccines and immunoglobulins

Scandinavian Biopharma

Welcome to Scandinavian Biopharma,

We are an entrepreneurial company specialised in global vaccine development, manufacturing, registration and commercialization of biopharmaceutical products. Our team has previously successfully developed, manufactured, registered and globally l[...]
Read more


Scandinavian Biopharma

The successful immunogenicity and safety results of ETVAX® are presented at Vaccines for Enteric Diseases (VED) Oct 16-18 in Lausanne, Switzerland

Lausanne, Switzerland, Wednesday Oct 16 As a world leading company within diarrhoeal vaccine development, Scandinavian Biopharma is regularly invited to participate in global conferences that bring together renowned researchers and decision m[...]
Read more

Scandinavian Biopharma

Scandinavian Biopharma awarded and qualified “Gazelle Company” by Dagens Industri

We are excited to share that we have been awarded the honourable title Gazelle company by Dagens Industri, DI. This means that we belong to the fastest growing companies in Sweden that are financially profitable with strong financial position. [...]
Read more